Hanmi awarded patent prize from KIPO

Published: 2003-12-24 06:58:00

Updated: 2003-12-24 06:58:00

Hanmi Pharm said that it received a Choongmugong Award from the Korean Intellectual Property Office on December 19 in recognition of its successful development for novel antihypertensive amlodipine camsylate, improved chemical entity with better stability after intensive three-year studies.

Of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK